Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: baseline characteristics of patients in the RESHAPE-HF2 trial
13 May 2024 (09:18 - 09:26)
Organised by: 
Slides
About the speaker
Charite University Hospital, Berlin (Germany)
9 More presentations in this session
Professor S. von Haehling (Goettingen, DE)
Professor M. Petrie (Glasgow, GB)
Access the full session
The Event
Heart Failure 2024
13 May 2024
09:18 CET
You may be interested in
Congress Presentation
Congress Presentation
